康龙化成拟1亿参投产业基金 行业复苏2024年预盈超17.29亿

长江商报
21 Mar

CRO龙头企业 康龙化成 (300759.SZ,03759.HK)拟扩大投资。3月19日晚间,康龙化成发布公告称,拟作为有限合伙人认缴出资1亿元参与投资宁波甬康股权投资合伙企业(有限合伙)(下称“基金”),该基金将主要关注宁波市的生命健康行业的项目。投资产业基金,康龙化成旨在放大投资能力,把握产业发展机会,提升未来盈利能力。随着全球 生物医药 行业投融资的初步复苏,康龙化成的业绩实现增长,2024...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10